Congratulations and thanks to the task force led by Dr. Pekka Talke for taking the challenge to produce the first Guidelines on behalf of the Society for Neuroscience in Anesthesiology and Critical Care (SNACC). The team's collaborative effort has resulted in timely and expert recommendations regarding the perioperative care of patients undergoing endovascular treatment for acute ischemic stroke (AIS).
With the recent rapid expansion of interventional therapy, anesthesiologists are increasingly involved in the acute care of ischemic stroke patients. This consensus document will definitely be helpful at many critical decision points in perioperative stroke care. Despite being in the era of evidence-based medicine, these Guidelines unfortunately had to be based largely on expert experience and opinions because there are very few studies to guide anesthesia practice.
Globally, stroke is a leading cause of death and significant long-term disability. From patient factors to health care delivery, stroke care has been a top priority in both clinical practice and scientific research efforts over the past 30 years. The development of endovascular approaches has been enthusiastically embraced as offering an alternative, and in some cases, an even better therapeutic outcome for the FDA-approved tissue plasminogen activator (iv tPA) treatment of AIS. This is especially true for occlusions in large cerebral arteries. However, recent multicenter randomized clinical trials failed to prove the superiority of endovascular treatment, which shocked many and dampened some enthusiasm for endovascular approaches. Much of the criticism pointed to the lack of application of newer mechanical devices that could potentially provide much quicker and more effective racanalization, compared to the earlier devices used in the studies. These studies, in fact, have highlighted the potential value of optimizing medical care of AIS patients besides achieving recanalization and restoration of blood flow to the ischemic brain. The anesthesia debate has so far focused on whether general anesthesia is good or bad. Since some, or perhaps most, interventionalists prefer general anesthesia 8 (and some patients will need it for clinical reasons), it seems that the fundamental focus should be on how best to manage anesthesia, whether it be MAC or general. As there is no convincing evidence that general anesthetic agents are detrimental in (experimental) cerebral ischemia, it would seem that the problem lies in management goals rather than agents. The debate has at least raised the awareness of the medical community regarding the importance of appropriate peri-procedural anesthetic management. Now is the time for well-focused and well-conducted studies that will involve our collaborative efforts with various stroke care specialties. The task force on Acute Ischemic Stroke has taken the first step in creating Guidelines in the absence of much-needed evidence. There isn't a more opportune time for the SNACC membership to play leading roles in this journey and demonstrate our commitment to discover evidence that will shape our clinical practice and provide better and safer perioperative care of stroke patients.
